HINT2 and metabolic dysfunction-associated steatohepatitis: To explore the regulatory effects of HINT2 in the next stages of MASLD, we induced a metabolic dysfunction-associated steatohepatitis (MASH) mouse model using WD + SW (Fig. 4a).